Beta-Defensin-1 vs Teixobactin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin-1 (HBD-1) is a constitutively expressed antimicrobial peptide produced by epithelial cells of the skin, respiratory tract, and genitourinary system. Unlike inducible defensins, HBD-1 is present at steady-state levels as a component of basal innate immune defen...
Calculate Beta-Defensin-1 dose →Teixobactin was reported in Nature in 2015 as the first new antibiotic class discovered in 30 years, isolated from uncultured soil bacteria Eleftheria terrae using the iChip (isolation chip) technology that allows cultivation of previously unculturable organisms. Teixobactin bind...
Calculate Teixobactin dose →| Parameter | Beta-Defensin-1 | Teixobactin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | Hours | Hours (in vivo) |
| Typical Dose | N/A (endogenous) | N/A |
| Frequency | Constitutive | N/A |
| Route | Endogenous | Research only (IV in animal studies) |
| FDA Status | Not approved | Not approved (preclinical) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.